Board Meeting Details
The Board of Directors meeting is scheduled for Thursday, 5th November 2026. The primary agenda includes consideration and approval of:
- Standalone Un-Audited (Provisional) Financial Results for the second quarter ended 30th September 2026
- Consolidated Un-Audited (Provisional) Financial Results for the second quarter ended 30th September 2026
- Standalone Un-Audited (Provisional) Financial Results for the half year ended 30th September 2026
- Consolidated Un-Audited (Provisional) Financial Results for the half year ended 30th September 2026
This meeting is convened in compliance with Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Trading Window Closure Details
The trading window for dealing in the company's equity shares remains closed for all designated persons as defined under the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders.
Closure Period: From Thursday, 1st October 2026 until Saturday, 7th November 2026
Reopening Date: Sunday, 8th November 2026
The closure was initially communicated via letter dated 25th September 2026 and is extended due to the board meeting scheduled for results consideration. This complies with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Financial Impact
Financial impact not quantified in this disclosure. The actual financial results will be considered and approved in the upcoming board meeting.